• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION WALLFLEX ESOPHAGEAL; PROSTHESIS, ESOPHAGEAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION WALLFLEX ESOPHAGEAL; PROSTHESIS, ESOPHAGEAL Back to Search Results
Model Number M00516210
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Dysphagia/ Odynophagia (1815)
Event Date 01/17/2024
Event Type  Injury  
Manufacturer Narrative
Block h6: imdrf patient code e1009 captures the reportable event of dysphagia.Imdrf impact code f2301 is being used to capture the removal of the stent.
 
Event Description
Note: this report pertains to one of three devices used in the same patient.Refer to manufacturer reports # 3005099803-2023-06204, 3005099803-2024-00099 for the associated device information.It was reported to boston scientific corporation that a wallflex fully covered esophageal stent was implanted on (b)(6) 2023, in the middle esophagus to address a persistent dysphagia after two previously implanted agile esophageal stents performed (b)(6) 2023 respectively.The patient's anatomy was tortuous.On (b)(6) 2023, the patient was implanted with an agile esophageal partially covered stent (the subject of mfr.Report # 3005099803-2024-00099) to treat a malignant stricture; however, on (b)(6) 2023, the patient presented with dysphagia prompting the physician to check the stent.Stent ingrowth was observed, and the stent was repositioned.On (b)(6) 2023, the patient again experienced dysphagia, thus, a second agile esophageal stent (the subject of mfr.Report # 3005099803-2023-06204) was implanted.Subsequently, on (b)(6) 2023, the patient again presented with dysphagia which physician then observed a stent ingrowth.A wallflex esophageal stent (the subject of this report) was then implanted to restore patency.On (b)(6) 2024, the patient presented with dysphagia for the fourth time, thus, consequently, both the second agile and the wallflex esophageal stents were removed.A non-boston scientific stent was then placed stent-in-stent on the uncovered portion of the first agile esophageal stent.
 
Manufacturer Narrative
Block h6: imdrf patient code e1009 captures the reportable event of dysphagia.Imdrf impact code f2301 is being used to capture the removal of the stent.Block h11: correction to the initial mdr in block h6 (impact codes).
 
Event Description
Note: this report pertains to one of three devices used in the same patient.Refer to manufacturer reports # 3005099803-2023-06204, 3005099803-2024-00099, and 3005099803-2024-01133 for the associated device information.It was reported to boston scientific corporation that a wallflex fully covered esophageal stent was implanted on (b)(6) 2023, in the middle esophagus to address a persistent dysphagia after two previously implanted agile esophageal stents performed (b)(6)2023 and (b)(6) 2023 respectively.The patient's anatomy was tortuous.On (b)(6) 2023, the patient was implanted with an agile esophageal partially covered stent (the subject of mfr.Report # 3005099803-2024-00099) to treat a malignant stricture; however, on (b)(6) 2023, the patient presented with dysphagia prompting the physician to check the stent.Stent ingrowth was observed, and the stent was repositioned.On (b)(6) 2023, the patient again experienced dysphagia, thus, a second agile esophageal stent (the subject of mfr.Report # 3005099803-2023-06204) was implanted.Subsequently, on (b)(6) 2023, the patient again presented with dysphagia which physician then observed a stent ingrowth.A wallflex esophageal stent (the subject of this report) was then implanted to restore patency.On (b)(6) 2024, the patient presented with dysphagia for the fourth time, thus, consequently, both the second agile and the wallflex esophageal stents were removed.A non-boston scientific stent was then placed stent-in-stent on the uncovered portion of the first agile esophageal stent.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WALLFLEX ESOPHAGEAL
Type of Device
PROSTHESIS, ESOPHAGEAL
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key18935496
MDR Text Key338068653
Report Number3005099803-2024-01133
Device Sequence Number1
Product Code ESW
Combination Product (y/n)N
Reporter Country CodeSN
PMA/PMN Number
K091510
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/29/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberM00516210
Device Catalogue Number1621
Device Lot Number0032224095
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received03/19/2024
Supplement Dates Manufacturer Received04/11/2024
Supplement Dates FDA Received04/29/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/16/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-